Specifically, CX alleviates hepatic lipid metabolism disorders by enhancing antioxidant capacity, repairing hepatic tissue damage, and upregulating the expression of lipid synthesis-related genes (FASN, ACC, ME, SREBP-1c, and LXRα). This evidence concerns the gene FASN and hepatitis A virus infection.